Literature DB >> 1733515

The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice.

M A Duchosal1, S A Eming, P J McConahey, F J Dixon.   

Abstract

We present a 2-year serologic analysis of severe combined immune deficiency (SCID) mice populated with human peripheral blood leukocytes (PBL, hu-PBL-SCID mice). After 10-20 x 10(6) PBL transfer, human IgG serum levels generally increased in the SCID mouse recipient for 2 months, and thereafter decreased without returning to zero for at least 2 years. Great variability existed between different hu-PBL-SCID mice with regard to Ig serum levels even when derived from the same donor's PBL aliquot. The ratio of IgM to IgG serum levels was lower in hu-PBL-SCID mice than in the donors. The half-life of human IgG in the SCID mouse is shorter than in the human (8 days vs 23 days), suggesting a much higher production of IgG than expected from serum levels. The majority of hu-PBL-SCID mouse sera analyzed by high resolution electrophoresis had a smear appearance suggestive of diverse human Ig, generally with superimposed multiple faint mIg. Few mice developed strong human mIg, associated with lymphoproliferative diseases. In the hu-PBL-SCID mouse model, the transfer of cells from donors making antibody with defined specificity against TT and nuclear antigen resulted in the appearance of these antibodies in only a minority of the recipients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733515     DOI: 10.1016/0008-8749(92)90086-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Xenogenic transfer of human lymphocytes in tolerized mice.

Authors:  M M Gore; R M Kolhapure; M K Govardhan; K Banerjee
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

3.  Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.

Authors:  M A Duchosal; S A Eming; P J McConahey; F J Dixon
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

4.  Control of human thyroid autoantibody production in SCID mice.

Authors:  L M Macht; R J Corrall; J P Banga; C J Elson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

5.  Biochemical and functional characterization of xenoreactive natural antibodies in hu-PBL-SCID mice.

Authors:  B Naziruddin; R Shiroki; S Shishido; T Howard; T Mohanakumar
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

6.  Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.

Authors:  H L Spiegelberg; L Beck; H P Kocher; W C Fanslow; A H Lucas
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.